These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17392822)

  • 1. Inhibition of myc promoter and telomerase activity and induction of delayed apoptosis by SYUIQ-5, a novel G-quadruplex interactive agent in leukemia cells.
    Liu JN; Deng R; Guo JF; Zhou JM; Feng GK; Huang ZS; Gu LQ; Zeng YX; Zhu XF
    Leukemia; 2007 Jun; 21(6):1300-2. PubMed ID: 17392822
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of cell proliferation by quindoline derivative (SYUIQ-05) through its preferential interaction with c-myc promoter G-quadruplex.
    Ou TM; Lin J; Lu YJ; Hou JQ; Tan JH; Chen SH; Li Z; Li YP; Li D; Gu LQ; Huang ZS
    J Med Chem; 2011 Aug; 54(16):5671-9. PubMed ID: 21774525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The G-quadruplex ligand, SYUIQ-FM05, targets proto-oncogene c-kit transcription and induces apoptosis in K562 cells.
    Shen FH; Jin J; Li J; Wang Y; Zhu SH; Lu YJ; Ou TM; Huang ZS; Huang M; Huang ZY
    Pharm Biol; 2013 Apr; 51(4):447-54. PubMed ID: 23363047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senescence and telomere shortening induced by novel potent G-quadruplex interactive agents, quindoline derivatives, in human cancer cell lines.
    Zhou JM; Zhu XF; Lu YJ; Deng R; Huang ZS; Mei YP; Wang Y; Huang WL; Liu ZC; Gu LQ; Zeng YX
    Oncogene; 2006 Jan; 25(4):503-11. PubMed ID: 16170347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A G-quadruplex ligand SYUIQ-5 induces autophagy by inhibiting the Akt-FOXO3a pathway in nasopharyngeal cancer cells].
    Zhou WJ; Deng R; Feng GK; Zhu XF
    Ai Zheng; 2009 Oct; 28(10):1049-53. PubMed ID: 19799812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gaining insights into the small molecule targeting of the G-quadruplex in the c-MYC promoter using NMR and an allele-specific transcriptional assay.
    Kaiser CE; Gokhale V; Yang D; Hurley LH
    Top Curr Chem; 2013; 330():1-21. PubMed ID: 22752577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer.
    Chan DS; Yang H; Kwan MH; Cheng Z; Lee P; Bai LP; Jiang ZH; Wong CY; Fong WF; Leung CH; Ma DL
    Biochimie; 2011 Jun; 93(6):1055-64. PubMed ID: 21377506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of triethylene tetraamine on the G-quadruplex structure in the human c-myc promoter.
    Yin F; Liu J; Deng X; Wang J
    J Biochem; 2007 May; 141(5):669-74. PubMed ID: 17339229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico identification of novel ligands for G-quadruplex in the c-MYC promoter.
    Kang HJ; Park HJ
    J Comput Aided Mol Des; 2015 Apr; 29(4):339-48. PubMed ID: 25527072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-MYC G-quadruplex binding by the RNA polymerase I inhibitor BMH-21 and analogues revealed by a combined NMR and biochemical Approach.
    Musso L; Mazzini S; Rossini A; Castagnoli L; Scaglioni L; Artali R; Di Nicola M; Zunino F; Dallavalle S
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):615-629. PubMed ID: 29229300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia.
    Tauchi T; Shin-ya K; Sashida G; Sumi M; Okabe S; Ohyashiki JH; Ohyashiki K
    Oncogene; 2006 Sep; 25(42):5719-25. PubMed ID: 16652154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of Pt-ttpy with G-Quadruplexes Originating from Promoter Region of the c-myc Gene Deciphered by NMR and Gel Electrophoresis Analysis.
    Trajkovski M; Morel E; Hamon F; Bombard S; Teulade-Fichou MP; Plavec J
    Chemistry; 2015 May; 21(21):7798-807. PubMed ID: 25847573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the equilibrium between G-quadruplex and duplex DNA in promoter of human c-myc oncogene by a pyrene derivative.
    Zhang Z; He X; Yuan G
    Int J Biol Macromol; 2011 Dec; 49(5):1173-6. PubMed ID: 21683090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-Induced Dimerization of a Truncated Parallel MYC G-Quadruplex.
    Funke A; Karg B; Dickerhoff J; Balke D; Müller S; Weisz K
    Chembiochem; 2018 Mar; 19(5):505-512. PubMed ID: 29228465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quadruplex forming promoter region of c-myc oncogene as a potential target for a telomerase inhibitory plant alkaloid, chelerythrine.
    Ghosh S; Dasgupta D
    Biochem Biophys Res Commun; 2015 Mar; 459(1):75-80. PubMed ID: 25712523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer activity and cellular repression of c-MYC by the G-quadruplex-stabilizing 11-piperazinylquindoline is not dependent on direct targeting of the G-quadruplex in the c-MYC promoter.
    Boddupally PV; Hahn S; Beman C; De B; Brooks TA; Gokhale V; Hurley LH
    J Med Chem; 2012 Jul; 55(13):6076-86. PubMed ID: 22691117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 9-N-Substituted berberine derivatives: stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc.
    Ma Y; Ou TM; Hou JQ; Lu YJ; Tan JH; Gu LQ; Huang ZS
    Bioorg Med Chem; 2008 Aug; 16(16):7582-91. PubMed ID: 18674916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives.
    Ou TM; Lu YJ; Zhang C; Huang ZS; Wang XD; Tan JH; Chen Y; Ma DL; Wong KY; Tang JC; Chan AS; Gu LQ
    J Med Chem; 2007 Apr; 50(7):1465-74. PubMed ID: 17346034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting pancreatic cancer with a G-quadruplex ligand.
    Gunaratnam M; de la Fuente M; Hampel SM; Todd AK; Reszka AP; Schätzlein A; Neidle S
    Bioorg Med Chem; 2011 Dec; 19(23):7151-7. PubMed ID: 22041170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Turning off transcription of the bcl-2 gene by stabilizing the bcl-2 promoter quadruplex with quindoline derivatives.
    Wang XD; Ou TM; Lu YJ; Li Z; Xu Z; Xi C; Tan JH; Huang SL; An LK; Li D; Gu LQ; Huang ZS
    J Med Chem; 2010 Jun; 53(11):4390-8. PubMed ID: 20481493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.